KDELR2 and glioblastoma: Besides this, the KDELR2 overexpression in GBM cells significantly increases mTOR phosphorylation, suggesting that KDELR2 could activate the mTORC1 pathway, which is correlated with cell proliferation and tumor aggressiveness (Ghosh and Kapur 2017).